Past and future of alveolar organoids for lung regenerative medicine

The lung is regarded as having limited regenerative capacity, and there are few treatment options for refractory lung diseases, such as interstitial pneumonia. Lung transplantation is the final option available in some scenarios. Research in this area has been slow owing to the complex structure of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Stem cells (Dayton, Ohio) Ohio), 2024-06, Vol.42 (6), p.491-498
Hauptverfasser: Mikawa, Ryuta, Gotoh, Shimpei
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 498
container_issue 6
container_start_page 491
container_title Stem cells (Dayton, Ohio)
container_volume 42
creator Mikawa, Ryuta
Gotoh, Shimpei
description The lung is regarded as having limited regenerative capacity, and there are few treatment options for refractory lung diseases, such as interstitial pneumonia. Lung transplantation is the final option available in some scenarios. Research in this area has been slow owing to the complex structure of the lung for efficient gas exchange between the alveolar spaces and capillaries as well as the difficulty in obtaining specimens from patients with progressive lung disease. However, basic research over the past decade in the field of mouse and human embryology using genetic lineage tracing techniques and stem cell biology using primary and pluripotent stem cell-derived alveolar organoids has begun to clarify the tissue response in various intractable lung diseases and the mechanisms underlying remodeling. Advancement in this area may expand potential therapeutic targets for alveolar regeneration, providing alternatives to lung transplantation, and contribute to the development of effective therapeutic methods that activate or repopulate stem cells in the lung. In this review, we cover research focused on alveolar epithelial cells and discuss methods expected to regenerate lungs that are damaged by diseases.
doi_str_mv 10.1093/stmcls/sxae024
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2985795713</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2985795713</sourcerecordid><originalsourceid>FETCH-LOGICAL-c180t-69e602e3c68bc1df8dff9e7d4cec5aeb3e62a3ba713e60bdd44f3e878696f42b3</originalsourceid><addsrcrecordid>eNo9kDtPwzAUhS0EoqWwMiKPLKF2_Ig9ovKUKsEAc-TY11WQExc7qeDfE9TCdM_wnSPdD6FLSm4o0WyZh86GvMxfBkjJj9CcCq4Lrqk6njKRshBE6xk6y_mDEMqFUqdoxpQoJZHVHN29mjxg0zvsx2FMgKPHJuwgBpNwTBvTx9Zl7GPCYew3OMEGekhmaHeAO3CtbXs4RyfehAwXh7tA7w_3b6unYv3y-Ly6XReWKjIUUoMkJTArVWOp88p5r6Fy3IIVBhoGsjSsMRWdEmmc49wzUJWSWnpeNmyBrve72xQ_R8hD3bXZQgimhzjmutRKVFpM_Qm92aM2xZwT-Hqb2s6k75qS-tdcvTdXH8xNhavD9thMf_3jf6rYD042bcM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2985795713</pqid></control><display><type>article</type><title>Past and future of alveolar organoids for lung regenerative medicine</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Mikawa, Ryuta ; Gotoh, Shimpei</creator><creatorcontrib>Mikawa, Ryuta ; Gotoh, Shimpei</creatorcontrib><description>The lung is regarded as having limited regenerative capacity, and there are few treatment options for refractory lung diseases, such as interstitial pneumonia. Lung transplantation is the final option available in some scenarios. Research in this area has been slow owing to the complex structure of the lung for efficient gas exchange between the alveolar spaces and capillaries as well as the difficulty in obtaining specimens from patients with progressive lung disease. However, basic research over the past decade in the field of mouse and human embryology using genetic lineage tracing techniques and stem cell biology using primary and pluripotent stem cell-derived alveolar organoids has begun to clarify the tissue response in various intractable lung diseases and the mechanisms underlying remodeling. Advancement in this area may expand potential therapeutic targets for alveolar regeneration, providing alternatives to lung transplantation, and contribute to the development of effective therapeutic methods that activate or repopulate stem cells in the lung. In this review, we cover research focused on alveolar epithelial cells and discuss methods expected to regenerate lungs that are damaged by diseases.</description><identifier>ISSN: 1066-5099</identifier><identifier>EISSN: 1549-4918</identifier><identifier>DOI: 10.1093/stmcls/sxae024</identifier><identifier>PMID: 38526067</identifier><language>eng</language><publisher>England</publisher><subject>Animals ; Humans ; Lung - cytology ; Lung Diseases - pathology ; Lung Diseases - therapy ; Organoids - cytology ; Pulmonary Alveoli - cytology ; Regeneration - physiology ; Regenerative Medicine - methods</subject><ispartof>Stem cells (Dayton, Ohio), 2024-06, Vol.42 (6), p.491-498</ispartof><rights>The Author(s) 2024. Published by Oxford University Press. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c180t-69e602e3c68bc1df8dff9e7d4cec5aeb3e62a3ba713e60bdd44f3e878696f42b3</cites><orcidid>0000-0002-8563-8200</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38526067$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mikawa, Ryuta</creatorcontrib><creatorcontrib>Gotoh, Shimpei</creatorcontrib><title>Past and future of alveolar organoids for lung regenerative medicine</title><title>Stem cells (Dayton, Ohio)</title><addtitle>Stem Cells</addtitle><description>The lung is regarded as having limited regenerative capacity, and there are few treatment options for refractory lung diseases, such as interstitial pneumonia. Lung transplantation is the final option available in some scenarios. Research in this area has been slow owing to the complex structure of the lung for efficient gas exchange between the alveolar spaces and capillaries as well as the difficulty in obtaining specimens from patients with progressive lung disease. However, basic research over the past decade in the field of mouse and human embryology using genetic lineage tracing techniques and stem cell biology using primary and pluripotent stem cell-derived alveolar organoids has begun to clarify the tissue response in various intractable lung diseases and the mechanisms underlying remodeling. Advancement in this area may expand potential therapeutic targets for alveolar regeneration, providing alternatives to lung transplantation, and contribute to the development of effective therapeutic methods that activate or repopulate stem cells in the lung. In this review, we cover research focused on alveolar epithelial cells and discuss methods expected to regenerate lungs that are damaged by diseases.</description><subject>Animals</subject><subject>Humans</subject><subject>Lung - cytology</subject><subject>Lung Diseases - pathology</subject><subject>Lung Diseases - therapy</subject><subject>Organoids - cytology</subject><subject>Pulmonary Alveoli - cytology</subject><subject>Regeneration - physiology</subject><subject>Regenerative Medicine - methods</subject><issn>1066-5099</issn><issn>1549-4918</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kDtPwzAUhS0EoqWwMiKPLKF2_Ig9ovKUKsEAc-TY11WQExc7qeDfE9TCdM_wnSPdD6FLSm4o0WyZh86GvMxfBkjJj9CcCq4Lrqk6njKRshBE6xk6y_mDEMqFUqdoxpQoJZHVHN29mjxg0zvsx2FMgKPHJuwgBpNwTBvTx9Zl7GPCYew3OMEGekhmaHeAO3CtbXs4RyfehAwXh7tA7w_3b6unYv3y-Ly6XReWKjIUUoMkJTArVWOp88p5r6Fy3IIVBhoGsjSsMRWdEmmc49wzUJWSWnpeNmyBrve72xQ_R8hD3bXZQgimhzjmutRKVFpM_Qm92aM2xZwT-Hqb2s6k75qS-tdcvTdXH8xNhavD9thMf_3jf6rYD042bcM</recordid><startdate>20240614</startdate><enddate>20240614</enddate><creator>Mikawa, Ryuta</creator><creator>Gotoh, Shimpei</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8563-8200</orcidid></search><sort><creationdate>20240614</creationdate><title>Past and future of alveolar organoids for lung regenerative medicine</title><author>Mikawa, Ryuta ; Gotoh, Shimpei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c180t-69e602e3c68bc1df8dff9e7d4cec5aeb3e62a3ba713e60bdd44f3e878696f42b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Animals</topic><topic>Humans</topic><topic>Lung - cytology</topic><topic>Lung Diseases - pathology</topic><topic>Lung Diseases - therapy</topic><topic>Organoids - cytology</topic><topic>Pulmonary Alveoli - cytology</topic><topic>Regeneration - physiology</topic><topic>Regenerative Medicine - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mikawa, Ryuta</creatorcontrib><creatorcontrib>Gotoh, Shimpei</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Stem cells (Dayton, Ohio)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mikawa, Ryuta</au><au>Gotoh, Shimpei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Past and future of alveolar organoids for lung regenerative medicine</atitle><jtitle>Stem cells (Dayton, Ohio)</jtitle><addtitle>Stem Cells</addtitle><date>2024-06-14</date><risdate>2024</risdate><volume>42</volume><issue>6</issue><spage>491</spage><epage>498</epage><pages>491-498</pages><issn>1066-5099</issn><eissn>1549-4918</eissn><abstract>The lung is regarded as having limited regenerative capacity, and there are few treatment options for refractory lung diseases, such as interstitial pneumonia. Lung transplantation is the final option available in some scenarios. Research in this area has been slow owing to the complex structure of the lung for efficient gas exchange between the alveolar spaces and capillaries as well as the difficulty in obtaining specimens from patients with progressive lung disease. However, basic research over the past decade in the field of mouse and human embryology using genetic lineage tracing techniques and stem cell biology using primary and pluripotent stem cell-derived alveolar organoids has begun to clarify the tissue response in various intractable lung diseases and the mechanisms underlying remodeling. Advancement in this area may expand potential therapeutic targets for alveolar regeneration, providing alternatives to lung transplantation, and contribute to the development of effective therapeutic methods that activate or repopulate stem cells in the lung. In this review, we cover research focused on alveolar epithelial cells and discuss methods expected to regenerate lungs that are damaged by diseases.</abstract><cop>England</cop><pmid>38526067</pmid><doi>10.1093/stmcls/sxae024</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-8563-8200</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1066-5099
ispartof Stem cells (Dayton, Ohio), 2024-06, Vol.42 (6), p.491-498
issn 1066-5099
1549-4918
language eng
recordid cdi_proquest_miscellaneous_2985795713
source MEDLINE; Oxford University Press Journals All Titles (1996-Current)
subjects Animals
Humans
Lung - cytology
Lung Diseases - pathology
Lung Diseases - therapy
Organoids - cytology
Pulmonary Alveoli - cytology
Regeneration - physiology
Regenerative Medicine - methods
title Past and future of alveolar organoids for lung regenerative medicine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T16%3A25%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Past%20and%20future%20of%20alveolar%20organoids%20for%20lung%20regenerative%20medicine&rft.jtitle=Stem%20cells%20(Dayton,%20Ohio)&rft.au=Mikawa,%20Ryuta&rft.date=2024-06-14&rft.volume=42&rft.issue=6&rft.spage=491&rft.epage=498&rft.pages=491-498&rft.issn=1066-5099&rft.eissn=1549-4918&rft_id=info:doi/10.1093/stmcls/sxae024&rft_dat=%3Cproquest_cross%3E2985795713%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2985795713&rft_id=info:pmid/38526067&rfr_iscdi=true